Home > Financial Ratios > VAISHALI PHARMA

VAISHALI PHARMA
EV/Core EBITDA

    Back to All Ratios
VAISHALI PHARMA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

VAISHALI PHARMA Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 46.0243.5414.3510.2811.55

What is the latest EV/Core EBITDA ratio of VAISHALI PHARMA ?

The latest EV/Core EBITDA ratio of VAISHALI PHARMA is 46.02 based on Mar2025 Standalone results.
Year EV/Core EBITDA
Mar202546.02
Mar202443.54
Mar202314.35
Mar202210.28
Mar202111.55

How is EV/Core EBITDA of VAISHALI PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2025 46.02
5.70
Mar2024 43.54
203.41
Mar2023 14.35
39.59
Mar2022 10.28
-11.00
Mar2021 11.55 -

Other Financial Ratios of VAISHALI PHARMA


Compare EV/Core EBITDA ratio of peers of VAISHALI PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VAISHALI PHARMA ₹79.9 Cr -6% -24.2% -53.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹432,000.0 Cr -0.4% 5.3% 13.4% Stock Analytics
DIVIS LABORATORIES ₹161,076.0 Cr -4.3% -6.3% 12.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,510.0 Cr 0.4% 8.2% 44.7% Stock Analytics
DR REDDYS LABORATORIES ₹107,921.0 Cr 0.5% 1.8% 16.4% Stock Analytics
CIPLA ₹106,150.0 Cr -0.8% -2.6% -9.2% Stock Analytics


VAISHALI PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VAISHALI PHARMA

-6%

-24.2%

-53.3%

SENSEX

-5.5%

-11.5%

0.3%


You may also like the below Video Courses